Bio Essence Corp (OTC:BIOE)

US · Delayed Price · Currency is USD

0.30-0.12 (-28.57%)

Market Cap	11.88M+324.8%
Revenue (ttm)	2.91M+416.6%
Net Income	1.52M+210.5%
EPS	0.04+203.3%
Shares Out	39.60M
PE Ratio	8.04
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,938
Open	0.39
Previous Close	0.42
Day's Range	0.27 - 0.42
52-Week Range	0.05 - 0.52
Beta	6.10
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

-28.57% (1D)

No price history available.

Full Chart

Alerts Compare

Insider Score

––Not scored

BIOE Insider Score

No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.

See stocks that are scored

About BIOE

Bio Essence Corporation is a global enterprise specializing in herbal health, dietary, and nutritional solutions. It supplies healthcare professionals with a diverse range of herbal remedies, offered in various forms such as granules, capsules, pills, and tablets. Furthermore, the company extends custom formulation and original equipment manufacturing (OEM) services to these practitioners and manufactures and distributes its own line of health supplements. Founded in 2000, Bio Essence Corporation maintains its corporate headquarters in Irvine, California.

Address

2955 Main Street, Irvine, CA, 92618, US

Market Cap

12 million

Employees

Industrial Classification

Drug Manufacturers - Specialty & Generic

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling

Sold

$432.04K

Bought

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day

-28.57%

5 Days

+12.36%

1 Month

+64.84%

6 Months

-25.00%

1 Year

+324.80%

$BIOE stock is featured in our Insider Trades datasets.

→ All Stock Lists

Whale Activity →

Recently reported changes in BIOE holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by BIOE's directors and management

No SEC Form 4 activity for BIOE in the last 5 quarters.

Source: SEC EDGAR (Form 4)

Corporate Lobbying

BIOE Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New BIOE patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to BIOE from public contracts

Source: USAspending.gov

BIOE Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

No Insider Score for BIOE yet — no open-market insider buys or sells in the last 90 days.

Bull Case vs Bear Case

AI-generated from BIOE’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys

Sells

Buy Value

Distinct Buyers

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.